<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Laquinimod for multiple sclerosis - He, D - 2013 | Cochrane Library</title> <meta content="Laquinimod for multiple sclerosis - He, D - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010475.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Laquinimod for multiple sclerosis - He, D - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010475.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010475.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Laquinimod for multiple sclerosis" name="citation_title"/> <meta content="Dian He" name="citation_author"/> <meta content="Affiliated Hospital of Guiyang Medical College" name="citation_author_institution"/> <meta content="Kai Han" name="citation_author"/> <meta content="Jinan No. 6 People's Hospital" name="citation_author_institution"/> <meta content="Xiangdong Gao" name="citation_author"/> <meta content="Jinan No. 6 People's Hospital" name="citation_author_institution"/> <meta content="Shuai Dong" name="citation_author"/> <meta content="Jinan No. 6 People's Hospital" name="citation_author_institution"/> <meta content="Lan Chu" name="citation_author"/> <meta content="Affiliated Hospital of Guiyang Medical College" name="citation_author_institution"/> <meta content="chulan8999@sohu.com" name="citation_author_email"/> <meta content="ZhanHui Feng" name="citation_author"/> <meta content="Affiliated Hospital of Guiyang Medical College" name="citation_author_institution"/> <meta content="Shan Wu" name="citation_author"/> <meta content="Affiliated Hospital of Guiyang Medical College" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD010475.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/08/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010475.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010475.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010475.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Immunosuppressive Agents [*administration &amp; dosage]; Multiple Sclerosis, Relapsing‐Remitting [*drug therapy, prevention &amp; control]; Quinolones [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Secondary Prevention" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010475.pub2&amp;doi=10.1002/14651858.CD010475.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010475\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010475\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010475.pub2",title:"Laquinimod for multiple sclerosis",firstPublishedDate:"Aug 6, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010475.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010475.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010475.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010475.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010475.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010475.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010475.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010475.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010475.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010475.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>793 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010475.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/appendices#CD010475-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Laquinimod for multiple sclerosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0002">Dian He</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0003">Kai Han</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0004">Xiangdong Gao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0005">Shuai Dong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Lan Chu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0007">ZhanHui Feng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information#CD010475-cr-0008">Shan Wu</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information/en#CD010475-sec-0086">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 August 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010475.pub2">https://doi.org/10.1002/14651858.CD010475.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010475-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010475-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010475-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010475-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010475-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010475-abs-0001" lang="en"> <section id="CD010475-sec-0001"> <h3 class="title" id="CD010475-sec-0001">Background</h3> <p>Multiple sclerosis (MS) is a chronic immune‐mediated, inflammatory, demyelinating, neurodegenerative disorder of the central nervous system, and it causes major socioeconomic burden for the individual patient and for society. An inflammatory pathology occurs during the early relapsing stage of MS and a neurodegenerative pathology dominates the later progressive stage of the disease. Not all MS patients respond adequately to currently available disease‐modifying drugs (DMDs). Alternative MS treatments with new modes of action are required to expand the current options for disease‐modifying therapies (DMTs) and to aim for freedom from relapses, inflammatory lesions, disability progression and neurodegeneration. Laquinimod has dual properties of immunomodulation and neuroprotection and is a potentially promising new oral DMD in the treatment of relapsing MS. </p> </section> <section id="CD010475-sec-0002"> <h3 class="title" id="CD010475-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety profile of laquinimod as monotherapy or combination therapy versus placebo or approved DMDs (interferon‐β, glatiramer acetate, natalizumab, mitoxantrone, fingolimod, teriflunomide, dimethyl fumarate) for modifying the disease course in patients with MS. </p> </section> <section id="CD010475-sec-0003"> <h3 class="title" id="CD010475-sec-0003">Search methods</h3> <p>The Review Group Trials Search Co‐ordinator searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group Specialised Register which, among other sources, contains trials from CENTRAL (<i>The Cochrane Library</i> 2013, Issue 2), MEDLINE, EMBASE, CINAHL, LILACS, PEDro and Clinical trials registries (29 April 2013). We checked references in identified trials and manually searched the reports (2004 to March 2013) from neurological associations and MS societies. We also communicated with researchers participating in trials on laquinimod and contacted Teva Pharmaceutical Industries. </p> </section> <section id="CD010475-sec-0004"> <h3 class="title" id="CD010475-sec-0004">Selection criteria</h3> <p>All randomised, double‐blind, controlled, parallel group clinical trials (RCTs) with a length of follow‐up of at least one year evaluating laquinimod, as monotherapy or combination therapy, versus placebo or approved DMDs for patients with MS. </p> </section> <section id="CD010475-sec-0005"> <h3 class="title" id="CD010475-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed trial quality. Disagreements were discussed and resolved by consensus among review authors. Principal investigators of included studies were contacted for additional data or confirmation of information. </p> </section> <section id="CD010475-sec-0006"> <h3 class="title" id="CD010475-sec-0006">Main results</h3> <p>Only one study met our inclusion criteria, involving 1106 adult patients with relapsing‐remitting MS (RRMS) and an entry Expanded Disability Status Scale (EDSS) score of ≤ 5.5 and an entry disease duration of ≥ 6 months. Five hundred and fifty patients treated with laquinimod at a dose of 0.6 mg orally administered once daily in a capsule were compared with 556 patients treated with a matching placebo capsule. The study had a high risk for attrition bias (21.9%). Laquinimod had potential benefits in reducing relapse rates and was safe for most patients with RRMS in the short term. The most common adverse events included headache, back pain, arthralgia, diarrhoea, cough, urinary tract infection, elevated alanine aminotransferase, insomnia, nausea, abdominal pain and sinusitis. One ongoing trial was identified. </p> </section> <section id="CD010475-sec-0007"> <h3 class="title" id="CD010475-sec-0007">Authors' conclusions</h3> <p>We found low‐level evidence for the use of laquinimod as a disease‐modifying therapy for MS because only one study with limited quality (high risk of attrition bias) was included. The published study suggests that laquinimod at a dose of 0.6 mg orally administered once daily may be safe and have potential benefits for most patients with RRMS in the short term. We are waiting for the publication of ongoing trials. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010475-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010475-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010475-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010475-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010475-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010475-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010475-abs-0004" lang="en"> <h3>Laquinimod, a new oral disease‐modifying drug for multiple sclerosis (MS)</h3> <p>Disease‐modifying therapies (DMTs) for MS currently aim to specifically reduce inflammation in relapsing MS and promote protection and repair of the nervous system in progressive MS. Laquinimod is a new oral disease‐modifying drug (DMD) with dual properties of modulation of the immune system and protection of the nervous system. The authors of this review assessed the efficacy and safety of laquinimod in patients with MS. Concerning the outcomes, they considered relapse, disability progression, inflammatory lesion, and brain atrophy. Among the pertinent literature only one study met the inclusion criteria. The study involved a total of 1106 patients with relapsing‐remitting MS and evaluated the efficacy and safety of laquinimod as unique therapy versus placebo. As far as safety was concerned, common adverse events included headache, back pain, arthralgia, diarrhoea, cough, urinary tract infection, elevated alanine aminotransferase, insomnia, nausea, abdominal pain and sinusitis. The authors were unable to give any clear recommendations for the use of laquinimod as a DMD for MS because the study was poor quality and was funded by a pharmaceutical company. Future studies with higher methodological quality are needed to assess the potential benefits and the safety in a longer period of administration. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010475-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010475-sec-0079"></div> <h3 class="title" id="CD010475-sec-0080">Implications for practice</h3> <section id="CD010475-sec-0080"> <p>We found low‐level evidence for the use of laquinimod as a disease‐modifying therapy for MS due to the limited quality of the available RCT. However, laquinimod at a dose of 0.6 mg administered orally once daily has potential benefits in reducing relapse rates, and the review shows it to be safe for most patients with RRMS in the short term. The most common adverse events included headache, back pain, arthralgia, diarrhoea, cough, urinary tract infection, elevated alanine aminotransferase, insomnia, nausea, abdominal pain and sinusitis. </p> </section> <h3 class="title" id="CD010475-sec-0081">Implications for research</h3> <section id="CD010475-sec-0081"> <p>Randomised controlled trials with high methodological quality and longer periods of observation are needed to assess safety, disability progression, and neuroprotection. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010475-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010475-sec-0022"></div> <section id="CD010475-sec-0023"> <h3 class="title" id="CD010475-sec-0023">Description of the condition</h3> <p>Multiple sclerosis (MS) is a chronic immune‐mediated, inflammatory, demyelinating, neurodegenerative disorder of the central nervous system (CNS) in which immunoreactions lead to myelin sheath attack and axon injury. It is characterised by recurrent relapses or progression, or both, typically striking adults during the primary productive time of their life and ultimately leading to severe neurological disability. </p> <section id="CD010475-sec-0024"> <h4 class="title">(1) The characteristics of MS</h4> <p>The overall incidence rate of MS in the world has been estimated as 3.6 cases per 100,000 person‐years in women and 2.0 cases in men (<a href="./references#CD010475-bbs2-0012" title="AlonsoA , HernánMA . Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology2008;71(2):129‐35. ">Alonso 2008</a>). It is estimated to affect 2.1 million people worldwide (<a href="./references#CD010475-bbs2-0032" title="National MS Society. Who gets MS?. http://www.nationalmssociety.org/about‐multiple‐sclerosis/what‐we‐know‐aboutms/who‐gets‐ms/index.aspx (Accessed 29 November 2012). ">National MS Society 2009</a>). There are four clinical phenotypes of MS. Initially, more than 80% of individuals with MS experience a relapsing‐remitting disease course (RRMS) characterised by clinical exacerbations of neurologic symptoms followed by complete or incomplete remission (<a href="./references#CD010475-bbs2-0028" title="LublinFD , ReingoldSC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996;46:907‐11. ">Lublin 1996</a>). After 10 to 20 years, or median age 39.1 years, about half of these people gradually accumulate irreversible neurologic deficits with or without clinical relapses (<a href="./references#CD010475-bbs2-0018" title="ConfavreuxC , VukusicS . Natural history of multiple sclerosis: a unifying concept. Brain2006;129(Pt 3):606‐16. ">Confavreux 2006</a>), which is known as secondary progressive MS (SPMS). Another 10% to 20% of individuals with MS are diagnosed with primary progressive MS (PPMS), clinically defined as a disease course without any clinical attacks or remission from onset (<a href="./references#CD010475-bbs2-0028" title="LublinFD , ReingoldSC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996;46:907‐11. ">Lublin 1996</a>). A significantly rarer form is progressive relapsing MS (PRMS), which initially presents as PPMS; however, during the course of the disease these individuals develop true neurologic exacerbations (<a href="./references#CD010475-bbs2-0044" title="TullmanMJ , OshinskyRJ , LublinFD , CutterGR . Clinical characteristics of progressive relapsing multiple sclerosis. Multiple Sclerosis2004;10(4):451‐4. ">Tullman 2004</a>). Growing evidence supports an inflammatory pathology occurring during the early relapsing stage of MS, and neurodegenerative pathology dominates the later progressive stage of the disease. Gray matter (GM) damage is shown to be frequent and extensive, and more pronounced in the progressive disease phases. Its underlying pathology is different from white matter damage in MS (<a href="./references#CD010475-bbs2-0023" title="HulstHE , GeurtsJJ . Gray matter imaging in multiple sclerosis: what have we learned?. BMC Neurology2011;11:153. ">Hulst 2011</a>). Diffuse meningeal inflammation through B‐cell follicle‐like structures is associated with cortical pathology and an accelerated clinical course in SPMS (<a href="./references#CD010475-bbs2-0020" title="FernándezÓ , Álvarez‐CermeñoJC , Arroyo‐GonzálezR , BrievaL , Calles‐HernándezMC , Casanova‐EstruchB , et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Revista de Neurologia2012;54(11):677‐91. ">Fernández 2012</a>). GM damage occurs early in the disease course, and correlates with future MS‐related disability (<a href="./references#CD010475-bbs2-0020" title="FernándezÓ , Álvarez‐CermeñoJC , Arroyo‐GonzálezR , BrievaL , Calles‐HernándezMC , Casanova‐EstruchB , et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Revista de Neurologia2012;54(11):677‐91. ">Fernández 2012</a>). </p> </section> <section id="CD010475-sec-0025"> <h4 class="title">(2) The socioeconomic burden of MS</h4> <p>MS causes major socioeconomic burden for the individual patient and for society. Productivity costs are a far more important economic factor, especially due to reduced employment, which are enhanced by the early age of disease onset (<a href="./references#CD010475-bbs2-0024" title="JennumP , WanscherB , FrederiksenJ , KjellbergJ . The socioeconomic consequences of multiple sclerosis: a controlled national study. European Neuropsychopharmacology2012;22(1):36‐43. ">Jennum 2012</a>). Mobility problems represent a considerable personal and social burden both financially and in terms of quality of life (<a href="./references#CD010475-bbs2-0034" title="PikeJ , JonesE , RajagopalanK , PiercyJ , AndersonP . Social and economic burden of walking and mobility problems in multiple sclerosis. BMC Neurology2012;12(1):94. ">Pike 2012</a>). From a patient's perspective an MS relapse is associated with a significant increase in economic costs as well as a decline in health‐related quality of life and functional ability (<a href="./references#CD010475-bbs2-0033" title="Oleen‐BurkeyM , Castelli‐HaleyJ , LageMJ , JohnsonKP . Burden of a multiple sclerosis relapse: the patient's perspective. Patient2012;5(1):57‐69. ">Oleen‐Burkey 2012</a>). Direct costs are mainly due to medical care in the earlier stages of disease; indirect costs are mainly due to disability and productivity loss in later stages (<a href="./references#CD010475-bbs2-0031" title="NaciH , FleurenceR , BirtJ , DuhigA . Economic burden of multiple sclerosis: a systematic review of the literature. Pharmacoeconomics2010;28(5):363‐79. ">Naci 2010</a>). Effective treatment that reduces relapse frequency and prevents progression could impact both costs and quality of life and may help to reduce the social burden of MS (<a href="./references#CD010475-bbs2-0025" title="KarampampaK , GustavssonA , MiltenburgerC , KindunduCM , SelchenDH . Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada. Journal of Population Therapeutics and Clinical Pharmacology2012;19(1):e11‐25. ">Karampampa 2012</a>). </p> </section> <section id="CD010475-sec-0026"> <h4 class="title">(3) The key issues of current disease‐modifying therapies (DMTs) for MS</h4> <p>DMTs for MS currently aim to specifically reduce inflammation in relapsing MS and promote neuroprotection and neurorepair in progressive MS. As the most promising endpoints, magnetic resonance imaging (MRI) measures the percentage brain volume change (PBVC) (<a href="./references#CD010475-bbs2-0013" title="BarkhofF , CalabresiPA , MillerDH , ReingoldSC . Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nature Reviews Neurology2009;5(5):256‐66. ">Barkhof 2009</a>; <a href="./references#CD010475-bbs2-0046" title="van denElskampIJ , BodenB , DattolaV , KnolDL , FilippiM , et al. Cerebral atrophy as outcome measure in short‐term phase 2 clinical trials in multiple sclerosis. Neuroradiology2010;52(10):875‐81. ">van den Elskamp 2010</a>), T1 hypointensity (black holes) and magnetisation transfer ratio (<a href="./references#CD010475-bbs2-0017" title="CadavidD , CheriyanJ , SkurnickJ , LincolnJA , WolanskyLJ , CookSD . New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta‐1b or glatiramer acetate. Journal of Neurology, Neurosurgery, and Psychiatry2009;80(12):1337‐43. ">Cadavid 2009</a>; <a href="./references#CD010475-bbs2-0049" title="ZivadinovR , HusseinS , BergslandN , MinagarA , DwyerMG . Magnetization transfer imaging of acute black holes in patients on glatiramer acetate. Frontiers in Bioscience (Elite Edition)2012;4:1496‐504. ">Zivadinov 2012</a>), and optical coherence tomography findings (the thickness of the retinal nerve fibre layer (RNFL) (<a href="./references#CD010475-bbs2-0020" title="FernándezÓ , Álvarez‐CermeñoJC , Arroyo‐GonzálezR , BrievaL , Calles‐HernándezMC , Casanova‐EstruchB , et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Revista de Neurologia2012;54(11):677‐91. ">Fernández 2012</a>; <a href="./references#CD010475-bbs2-0027" title="LidsterK , BakerD . Optical coherence tomography detection of neurodegeneration in multiple sclerosis. Current Drug Targets‐CNS &amp; Neurological Disorders2012;11(5):518‐27. ">Lidster 2012</a>), which are or will be used in neuroprotection trials. Freedom from disease, defined as freedom from relapses, the absence of disability progression, and freedom from gadolinium‐enhancing T1 or new T2 lesions detected by MRI , is used as the measure of success of DMT (<a href="./references#CD010475-bbs2-0021" title="FoxEJ , RhoadesRW . New treatments and treatment goals for patients with relapsing‐remitting multiple sclerosis. Current Opinion in Neurology2012;25 Suppl 1:11‐9. ">Fox 2012</a>). However, relapses, disability progression and increasing disability may still occur in patients receiving first‐line DMTs with frequent parenteral administration and even second‐line DMTs with the risk of severe adverse events. Furtheremore, administration of interferon‐β was not associated with a reduction in progression of disability among patients with RRMS (<a href="./references#CD010475-bbs2-0041" title="ShiraniA , ZhaoY , KarimME , EvansC , KingwellE , van derKopML , et al. Association between use of interferon beta and progression of disability in patients with relapsing‐remitting multiple sclerosis. JAMA2012;308(3):247‐56. ">Shirani 2012</a>). So far there is no DMT available that can completely halt the neurodegenerative changes associated with the disease. The unmet needs highlight the reasons for developing new DMTs for MS, focusing on superior efficacy, ease of administration, good tolerability, and long‐term safety. Therefore, alternative MS treatments with oral routes of administration and new modes of action are needed to expand the current treatment repertoire, increase patient satisfaction and adherence, and thereby improve efficacy. </p> </section> </section> <section id="CD010475-sec-0027"> <h3 class="title" id="CD010475-sec-0027">Description of the intervention</h3> <p>Laquinimod, an oral quinoline‐3‐carboxamide, is a derivative of roquinimex (Linomide) but does not have the adverse effects associated with roquinimex (such as pericarditis and myocardial infarction). It has dual properties in experimental autoimmune encephalomyelitis (EAE), immunomodulatory and neuroprotective capacities (<a href="./references#CD010475-bbs2-0011" title="AharoniR , SaadaR , EilamR , HayardenyL , SelaM , ArnonR . Oral treatment with laquinimod augments regulatory T‐cells and brain‐derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology2012;251(1‐2):14‐24. ">Aharoni 2012</a>). Analyses in EAE demonstrate that laquinimod reduces infiltration of leukocytes into sites of inflammation in the CNS and induces a T‐helper1 (Th1) cytokine to Th2/3 cytokine shift without inducing much immunosuppression (<a href="./references#CD010475-bbs2-0014" title="BrunmarkC , RunströmA , OhlssonL , SparreB , BrodinT , AströmM , et al. The new orally active immunoregulator laquinimod (ABR‐215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology2002;130(1‐2):163‐72. ">Brunmark 2002</a>; <a href="./references#CD010475-bbs2-0050" title="ZouLP , AbbasN , VolkmannI , NennesmoI , LeviM , WahrenB , et al. Suppression of experimental autoimmune neuritis by ABR‐215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue. Neuropharmacology2002;42(5):731‐9. ">Zou 2002</a>; <a href="./references#CD010475-bbs2-0048" title="YangJS , XuLY , XiaoBG , HedlundG , LinkH . Laquinimod (ABR‐215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF‐beta in Lewis rats. Journal of Neuroimmunology2004;156(1‐2):3‐9. ">Yang 2004</a>). Laquinimod might protect myelin and axons by decreasing interleukin (IL)‐17 levels and impairing the migratory capacity of lymphocytes (<a href="./references#CD010475-bbs2-0047" title="WegnerC , StadelmannC , PförtnerR , RaymondE , FeigelsonS , AlonR , et al. Laquinimod interferes with migratory capacity of T cells and reduces IL‐17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology2010;227(1‐2):133‐43. ">Wegner 2010</a>) and modulated B cell markers, mainly by increasing regulatory CD25, IL10 and CD86, decreasing IL4, and increasing IL10 and TGFβ in both B and T cells in a B cell‐mediated manner (<a href="./references#CD010475-bbs2-0043" title="ToubiE , NussbaumS , Staun‐RamE , SnirA , MelamedD , HayardenyL , et al. Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis. Journal of Neuroimmunology2012;251(1‐2):45‐54. ">Toubi 2012</a>). Laquinimod reduced trafficking of proinflammatory monocytes into the CNS (<a href="./references#CD010475-bbs2-0030" title="MishraMK , WangJ , SilvaC , MackM , YongVW . Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. The American Journal of Pathology2012;181(2):642‐51. ">Mishra 2012</a>) and skewed monocytes toward a regulatory phenotype and also acted via modulation of brain‐derived neurotrophic factor (BDNF), which may contribute to neuroprotection in MS patients (<a href="./references#CD010475-bbs2-0042" title="ThöneJ , EllrichmannG , SeubertS , PerugaI , LeeDH , ConradR , et al. Modulation of autoimmune demyelination by laquinimod via induction of brain‐derived neurotrophic factor. The American Journal of Pathology2012;180(1):267‐74. ">Thöne 2012</a>). Laquinimod modulates adaptive T cell immune responses via its effects on cells of the innate immune system, and may not influence T cells directly (<a href="./references#CD010475-bbs2-0040" title="Schulze‐TopphoffU , ShettyA , Varrin‐DoyerM , MolnarfiN , SaganSA , SobelRA , et al. Laquinimod, a quinoline‐3‐carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLOS One2012;7(3):e33797. ">Schulze‐Topphoff 2012</a>). Meanwhile, it downregulates the astrocytic proinflammatory response, which might have protective effects on myelin, oligodendrocytes and axons (<a href="./references#CD010475-bbs2-0016" title="BrückW , PförtnerR , PhamT , ZhangJ , HayardenyL , PiryatinskyV , et al. Reduced astrocytic NF‐κB activation by laquinimod protects from cuprizone‐induced demyelination. Acta Neuropathology2012;124(3):411‐24. ">Brück 2012</a>). </p> <p>Laquinimod has a high level of oral bioavailability, a small distribution volume (10 L) and a low rate of total clearance. The maximum plasma concentration of laquinimod is achieved within the first hour following its administration by mouth (per os) and in humans it is less than 5 μM after administration of 0.05 to 2.4 mg of the drug (<a href="./references#CD010475-bbs2-0019" title="FernándezO . Oral laquinimod treatment in multiple sclerosis. Neurologia2011;26(2):111‐7. ">Fernández 2011</a>). Laquinimod is metabolized through one of the cytochrome P450 (CYP) enzymes and is a substrate with low affinity for CYP3A4 in liver microsomes (<a href="./references#CD010475-bbs2-0045" title="TuvessonH , HallinI , PerssonR , SparreB , GunnarssonPO , SeidegårdJ . Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator. Drug Metabolism and Disposition2005;33(6):866‐72. ">Tuvesson 2005</a>). It is mainly eliminated through urine in four hydroxylated metabolites and two metabolically inactive de‐alkylated metabolites. Ketoconazole in humans might reach plasma levels that would have a metabolic effect on CYP3A4 and, as a result, might affect the elimination of laquinimod (<a href="./references#CD010475-bbs2-0019" title="FernándezO . Oral laquinimod treatment in multiple sclerosis. Neurologia2011;26(2):111‐7. ">Fernández 2011</a>). Laquinimod had good tolerability when used at doses ranging from 0.1 mg/d to 1.2 mg/d (<a href="./references#CD010475-bbs2-0038" title="PreiningerovaJ . Oral laquinimod therapy in relapsing multiple sclerosis. Expert Opinion on Investigational Drugs2009;18(7):985‐9. ">Preiningerova 2009</a>). </p> </section> <section id="CD010475-sec-0028"> <h3 class="title" id="CD010475-sec-0028">How the intervention might work</h3> <p>Preclinical studies have shown that  laquinimod reduces inflammation in the CNS, decreases demyelination, and prevents axonal damage in EAE mice (<a href="./references#CD010475-bbs2-0015" title="BrückW , WegnerC . Insight into the mechanism of laquinimod action. Journal of the Neurological Sciences2011;306(1‐2):173‐9. ">Brück 2011</a>). These results could translate its immunomodulatory and CNS‐protective effects into clinical benefits in patients with RRMS. Recent findings from clinical trials indicate that laquinimod has significant effects in reducing relapse rate and has some effect in reducing sustained disability progression as well as brain atrophy, with a good safety profile. </p> </section> <section id="CD010475-sec-0029"> <h3 class="title" id="CD010475-sec-0029">Why it is important to do this review</h3> <p>No systematic review currently exists in the peer‐reviewed literature that focuses on laquinimod for patients with MS. A systematic review of all randomised controlled trials is warranted to evaluate the effectiveness and safety of laquinimod for MS. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010475-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010475-sec-0030"></div> <p>To assess the effectiveness and safety profile of laquinimod as monotherapy or combination therapy versus placebo or approved disease‐modifying drugs (DMDs) (interferon‐β, glatiramer acetate, natalizumab, mitoxantrone, fingolimod, teriflunomide, dimethyl fumarate) for modifying the disease course in patients with MS. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010475-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010475-sec-0031"></div> <section id="CD010475-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010475-sec-0033"> <h4 class="title">Types of studies</h4> <p>All randomised, double‐blind, controlled, parallel group clinical trials (RCTs) evaluating laquinimod, as monotherapy or combination therapy, versus placebo or any other treatment for patients with MS. We excluded uncontrolled, non‐randomised or quasi‐randomised trials and trials with a length of follow‐up shorter than one year. </p> </section> <section id="CD010475-sec-0034"> <h4 class="title">Types of participants</h4> <p>We included patients aged over 18 years with a definite diagnosis of MS according to Poser's (<a href="./references#CD010475-bbs2-0037" title="PoserCM , PatyDW , ScheinbergL , McDonaldWI , DavisFA , EbersGC , et al. New diagnostic criteria for multiple sclerosis:guidelines for research protocols. Annals of Neurology1983;13(8):227‐31. ">Poser 1983</a>) or McDonald's (<a href="./references#CD010475-bbs2-0029" title="McDonaldWI , CompstonA , EdanG , GoodkinD , HartungHP , LublinFD , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology2001;50(1):121‐7. ">McDonald 2001</a>; <a href="./references#CD010475-bbs2-0035" title='PolmanCH , ReingoldSC , EdanG , FilippiM , HartungHP , KapposL , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology2005;58(6):840‐6. '>Polman 2005a</a>; <a href="./references#CD010475-bbs2-0036" title="PolmanCH , ReingoldSC , BanwellB , ClanetM , CohenJA , FilippiM , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology2011;69(2):292‐302. ">Polman 2011</a>) criteria, any clinical phenotypes categorised according to the classification of Lublin and Reingold (<a href="./references#CD010475-bbs2-0028" title="LublinFD , ReingoldSC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996;46:907‐11. ">Lublin 1996</a>), and Expanded Disability Status Scale (EDSS) (<a href="./references#CD010475-bbs2-0026" title="KurtzkeJF . Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology1983;33:1444‐52. ">Kurtzke 1983</a>) scores ≤ 6.0 with or without progression. </p> </section> <section id="CD010475-sec-0035"> <h4 class="title">Types of interventions</h4> <p>Experimental intervention: treatment with laquinimod orally, as monotherapy or combination therapy, without restrictions regarding dosage, administration frequency and duration of treatment. </p> <p>Control intervention: placebo or approved DMDs.</p> </section> <section id="CD010475-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD010475-sec-0037"> <h5 class="title">Primary outcomes</h5> <p>We assessed the following primary outcomes measured in the treatment phase and at the completion of follow‐up versus baseline. </p> <p>Efficacy</p> <p> <ol id="CD010475-list-0001"> <li> <p>The annualised rate of relapse at one year (or later), defined as the mean number of confirmed relapses per patient, adjusting for the duration of follow‐up to annualise it. Confirmed relapse is defined as the occurrence of new symptoms or worsening of previously stable or improving symptoms and signs not associated with fever or infection, occurring at least 30 days after the onset of a preceding relapse, lasting more than 24 hours. The relapse should be verified by objective neurologic changes as indicated by an increase of at least 0.5 point in EDSS score or at least one grade in two or more functional systems, or at least two grades in one functional system. </p> </li> <li> <p>The proportion of patients free of disability progression as assessed by the EDSS at one year (or later). We accepted the definitions of confirmed disability progression reported in the included trials. </p> </li> </ol> </p> <p>Safety profile<br/> The number of patients with adverse effects (AEs), number of patients with serious adverse events (SAEs) and number of patients who withdrew or dropped out from the study because of AEs, at one year (or later). </p> </section> <section id="CD010475-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p>We assessed the following secondary outcomes measured in the treatment phase and at the completion of follow‐up versus baseline. </p> <p> <ol id="CD010475-list-0002"> <li> <p>The sum of the number of gadolinium‐enhancing T1‐weighted lesions at one year (or later). Lesions that persisted for more than four weeks were counted more than once. </p> </li> <li> <p>The time to confirmed disease progression at one year (or later).</p> </li> <li> <p>The percentage brain volume change (PBVC) at one year (or later).</p> </li> </ol> </p> </section> </section> </section> <section id="CD010475-sec-0039"> <h3 class="title">Search methods for identification of studies</h3> <p>No language restrictions were applied to the search.</p> <section id="CD010475-sec-0040"> <h4 class="title">Electronic searches</h4> <p>The Review Group Trials Search Co‐ordinator searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group Trials Register (29 April 2013) which, among other sources, contains trials from: </p> <p>1. Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2013, Issue 2); </p> <p>2.  MEDLINE (PubMed) (1966 to 29 April 2013);</p> <p>3.  EMBASE (Embase.com) (1974 to 29 April 2013);</p> <p>4.  CINAHL (EBSCOhost) (1981 to 29 April 2013);</p> <p>5.  LILACS (Bireme) (1982 to 29 April 2013);</p> <p>6.  PEDro (1990 to 29 April 2013);</p> <p>7.  Clinical trials registries (<a href="http://clinicaltrials.gov" target="_blank">http://clinicaltrials.gov</a>). </p> <p>Information on the Group's Trials Register and details of search strategies used to identify trials can be found in the 'Specialised Register' section within the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group's <a href="http://mrw.interscience.wiley.com/cochrane/cochrane_clsysrev_crglist_fs.html" target="_blank">module</a>. The keywords used to search for trials for this review are listed in <a href="./appendices#CD010475-sec-0084">Appendix 1</a>. </p> </section> <section id="CD010475-sec-0041"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD010475-list-0003"> <li> <p>We checked reference lists of published reviews and retrieved articles for additional trials. </p> </li> <li> <p>We searched reports (2004 to March 2013) from the MS societies (National Multiple Sclerosis Society (United States, United Kingdom)) and the Congress of the European and Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS). </p> </li> <li> <p>We communicated personally with investigators participating in trials of laquinimod.</p> </li> <li> <p>We contacted Teva Pharmaceutical Industries (<a href="http://www.tevapharm.com/Pages/default.aspx" target="_blank">http://www.tevapharm.com/Pages/default.aspx</a>) in an effort to identify further studies. </p> </li> </ol> </p> </section> </section> <section id="CD010475-sec-0042"> <h3 class="title" id="CD010475-sec-0042">Data collection and analysis</h3> <section id="CD010475-sec-0043"> <h4 class="title">Selection of studies</h4> <p>Titles and abstracts of the citations retrieved by the literature search were screened independently for inclusion or exclusion by two review authors (He, Dong). The available full texts of potentially relevant studies were obtained for further assessment. The eligibility (on the basis of the information available in the published data) of these studies was evaluated independently. Papers that did not meet the inclusion criteria were listed in the 'Characteristics of excluded studies' table with the reasons for omission. Studies that lacked any publication were listed in the 'Characteristics of studies awaiting classification' when further information and data could not be obtained from the principal investigators. Any disagreement regarding inclusion was resolved by discussion or by referral to a third assessor (Chu), if necessary. </p> </section> <section id="CD010475-sec-0044"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (He, Dong) independently extracted the data from the selected trials using standardised forms. Information about study design, participants, intervention and outcome measures was extracted. Principal investigators of included studies were contacted so that they could provide additional data or confirmation of methodological aspects of the study. Disagreements were discussed and resolved by consensus among the review authors. </p> </section> <section id="CD010475-sec-0045"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The methodological criteria were based on the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, Version 5.1.0 (<a href="./references#CD010475-bbs2-0022" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org, The Cochrane Collaboration, 2011. ">Higgins 2011</a>). Two review authors (He, Dong) independently evaluated the methodological quality of the studies using the 'Risk of bias' tool under the domains of sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome and other biases. Disagreements among the review authors on the methodological quality of the identified studies were discussed and resolved by consensus. </p> </section> <section id="CD010475-sec-0046"> <h4 class="title">Measures of treatment effect</h4> <p>We did not enter any data into the RevMan analysis software (<a href="./references#CD010475-bbs2-0039" title="Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>) because only one study was included in this review. If data are available in future updates we will analyse them as follows. </p> <p>The pre‐set outcomes in this protocol involved counts and rates, dichotomous and continuous data, and time‐to‐event data. </p> <p>Both the number of relapses and new enhancing lesions are count data. Analyses of counts of rare events (Poisson data) often focus on rates (rates relate the counts to the amount of time during which they could have happened). Rate ratio, which compares the rate of events in the two groups by dividing one by the other, will be used to measure the treatment effect on counts of rare events. When measuring the treatment effect on counts of common events, the mean difference will be used to compare the difference in the mean number of events (possibly standardised to a unit time period) experienced by the participants in the intervention group compared with the participants in the control group. Both MS relapse and gadolinium‐enhancing T1‐weighted lesions are common events, therefore the mean difference will be used as the measure of treatment effect. </p> <p>For continuous outcomes, the mean difference or the standardised mean difference (SMD) will be calculated with 95% confidence interval (CI). Standard deviation will be calculated from CI, or t‐tests, when it is not reported. The percentage brain volume change (PBVC) is a continuous outcome, and the mean difference will be used as the measure of treatment effect. </p> <p>For dichotomous outcomes, individual and pooled statistics will be calculated as relative ratio (RR) or odds ratio (OR), the risk difference (RD) (also called the absolute risk reduction) and the number needed to treat (NNT). Both the proportion of patients free of disability progression and the number of patients with adverse effects are dichotomous outcomes, and we will use relative ratios (RR) as the measure of treatment effect. </p> <p>Time‐to‐event data can be analysed as dichotomous data when the status of all patients in a study is known at a fixed timepoint. The time to confirmed disability progression belongs to time‐to‐event data; we will used relative ratios (RR) or hazard ratios as the measure of treatment effect. </p> </section> <section id="CD010475-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>Most RCTs on laquinimod for MS are multi‐arm studies with two experimental intervention groups (0.1 mg/day, 0.3 mg/day, 0.6 mg/day or 1.2 mg/day of laquinimod) and a common control group, and involving repeated observations on participants. The pre‐set outcome measures in this review involve events that may reoccur. If meta‐analysis is conducted in future updates, we will combine all relevant experimental intervention groups (0.1 mg/day, 0.3 mg/day, 0.6 mg/day, 1.2 mg/day) in the study into a single group, and combine all relevant control intervention groups into a single control group, if there is a study with two control intervention groups treated with the same drug and different doses. Meanwhile, we will perform separate analyses based on the pre‐set outcomes in this review and the different periods of follow‐up. Counts of common events (MS relapse and gadolinium‐enhancing T1‐weighted lesions) will be treated in the same way as continuous outcome data. </p> </section> <section id="CD010475-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>We did not conduct meta‐analysis as only one study was included in this review. Trial authors were not contacted to gather missing data. If sufficient data are not available from published reports in future updates, trials authors will be contacted for further details. For dichotomous outcomes, the missing data will be analysed using an intention‐to‐treat analysis. For continuous outcomes, sensitivity analyses will be performed to assess the sensitivity of the results to the assumptions that are made. Best‐ and worst‐case scenarios will be considered for taking into account missing data. </p> </section> <section id="CD010475-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>The one study included in this review did not permit an assessment of heterogeneity. If more studies are included and further data become available in future updates, we will assess clinical heterogeneity by examining the characteristics of the studies, the similarity between the types of participants, the interventions and the outcomes as specified in the criteria for included studies. The variability in study design and risk of bias (methodological heterogeneity) will also be evaluated. When pooling trials in meta‐analyses, we will calculate the I<sup>2</sup> statistic to identify heterogeneity across studies. With I<sup>2</sup> &gt; 30% there is some level of heterogeneity (<a href="./references#CD010475-bbs2-0022" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org, The Cochrane Collaboration, 2011. ">Higgins 2011</a>). If tests for heterogeneity are statistically significant and inspection of the individual results suggests that it still logical to combine results, we will calculate the overall effects using a random‐effects model. </p> </section> <section id="CD010475-sec-0050"> <h4 class="title">Assessment of reporting biases</h4> <p>We could not perform an assessment of reporting biases due to the lack of adequate studies included in this review. If sufficient RCTs are identified in future updates, potential publication bias will be examined using a funnel plot. For continuous outcomes, the standard error will be used as the vertical axis and the mean difference will be used as the horizontal axis in funnel plots. For dichotomous outcomes, the odds ratios or risk ratios will be plotted on a logarithmic scale as the horizontal axis and the standard error will be used as the vertical axis. </p> </section> <section id="CD010475-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We were unable to conduct meta‐analysis because only one study was included in this review. We have given a descriptive summary of the results. When clinically and methodologically homogeneous RCTs are identified in future updates and heterogeneity tests suggest an I<sup>2</sup> &lt; 30%, or inspection of the individual results suggests that it still seems logical to combine results even though tests for heterogeneity are statistically significant, formal meta‐analysis using Review Manager software (<a href="./references#CD010475-bbs2-0039" title="Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>) will be conducted. Treatment effect estimates for each study and the weighted average of the treatment effects estimated in the individual studies (as a pooled treatment effect estimate) will be calculated, then a random‐effects model or fixed‐effect model will be selected according to the results of the heterogeneity tests. If it is assumed that each study is estimating exactly the same quantity, a fixed‐effect model will be performed, otherwise a random effects model will be used. For the outcomes treated as dichotomous data (the number of patients free of disability progression, the number of patients with adverse effects, and the time to confirmed disability progression), three fixed‐effect model methods (Mantel‐Haenszel, Peto, or inverse variance) and one random‐effects model method (DerSimonian and Laird) will be selected (the Peto method can only pool odds ratios whilst the other three methods can pool odds ratios, risk ratios, and risk differences). For the outcomes treated as continuous and count data (relapse, the number of gadolinium‐enhancing T1‐weighted lesions, and the PBVC), the inverse‐variance fixed‐effect model method and the inverse‐variance random‐effects model method will selected. </p> </section> <section id="CD010475-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We could not carry out subgroup analysis because of the paucity of data. In future updates and if further data become available we intend to undertake subgroup analyses according to: (1) different therapies (e.g. monotherapy, combined interferon (IFN)‐β therapy); (2) different MS patients (e.g. patients with RRMS or patients with progressive MS); (3) duration of follow‐up (e.g. 1 year, between 1 and 2 years, or more than 2 years); (4) baseline EDSS scores (e.g. ≤ 3.5, or between 3.5 and 6); (5) dosage level (e.g. 0.1 mg/day, 0.3 mg/day, 0.6 mg/day or 1.2 mg/day); (6) different duration of MS (e.g. 5 years or more than 5 years). </p> </section> <section id="CD010475-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>If a sufficient number of studies had been included, we would have undertaken sensitivity analyses to assess the robustness of our review results. Where possible, we will conduct sensitivity analyses to assess the influence on results of fixed‐effect model versus random‐effects model assumptions, of including trials at high risk of bias, as well as the effects of analysing by intention to treat and the effect size (for dichotomous outcomes, relative ratios versus odds ratios; and for continuous outcomes, the mean difference versus the standardised mean difference). Counts of common events will be treated in the same way as continuous outcome data. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010475-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010475-sec-0054"></div> <section id="CD010475-sec-0055"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010475-sec-0091" title="">Characteristics of included studies</a>; <a href="./references#CD010475-sec-0092" title="">Characteristics of excluded studies</a>; <a href="./references#CD010475-sec-0093" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD010475-sec-0094" title="">Characteristics of ongoing studies</a>. </p> <section id="CD010475-sec-0056"> <h4 class="title">Results of the search</h4> <p>In total, 82 articles were retrieved by the search strategies. After screening of titles and abstracts, nine articles were provisionally selected and the available full papers were obtained for further assessment for eligibility. We excluded seven articles. Two studies (<a href="./references#CD010475-bbs2-0007" title="PolmanC , BarkhofF , Sandberg‐WollheimM , LindeA , NordleO , NedermanT , et al. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology2005;64(6):987‐91. ">Polman 2005b</a>; <a href="./references#CD010475-bbs2-0002" title="ComiG , PulizziA , RovarisM , AbramskyO , ArbizuT , BoikoA , et al. Effect of laquinimod on MRI‐monitored disease activity in patients with relapsing‐remitting multiple sclerosis: a multicentre, randomised, double‐blind, placebo‐controlled phase IIb study. Lancet2008;371(9630):2085‐92. ">Comi 2008</a>) were randomised, double‐blind, placebo‐controlled, parallel group phase Ⅱ studies but the length of follow‐up was shorter than one year. One study (<a href="./references#CD010475-bbs2-0003" title="ComiG , AbramskyO , ArbizuT , BoykoA , GoldR , HavrdováE , et al. Oral laquinimod in patients with relapsing‐remitting multiple sclerosis: 36‐week double‐blind active extension of the multi‐centre, randomized, double‐blind, parallel‐group placebo‐controlled study. Multiple Sclerosis2010;16(11):1360‐6. ">Comi 2010</a>) was the double‐blind extension phase of the <a href="./references#CD010475-bbs2-0002" title="ComiG , PulizziA , RovarisM , AbramskyO , ArbizuT , BoikoA , et al. Effect of laquinimod on MRI‐monitored disease activity in patients with relapsing‐remitting multiple sclerosis: a multicentre, randomised, double‐blind, placebo‐controlled phase IIb study. Lancet2008;371(9630):2085‐92. ">Comi 2008</a> study without placebo treatment as a control, and the length of follow‐up was shorter than one year. Two articles (<a href="./references#CD010475-bbs2-0004" title="ComiG , JefferyD , KapposL , MontalbanX , BoykoA , FilippiM . Laquinimod slows disability progression and reduces severe relapses in the placebo‐controlled phase III ALLEGRO trial for the treatment of relapsing‐remitting multiple sclerosis. Multiple Sclerosis2011;17 Suppl 10:420‐1. ">Comi 2011</a>; <a href="./references#CD010475-bbs2-0006" title="FilippiM , RoccaM , DeStefanoN , JefferyD , KapposL , MontalbanX , et al. Oral laquinimod reduces MRI markers suggestive of irreversible tissue damage in RRMS: results from ALLEGRO, a placebo‐controlled phase III trial. Multiple Sclerosis2011;17 Suppl 10:146. ">Filippi 2011</a>) were multiple reports from the same study (<a href="./references#CD010475-bbs2-0001" title="ComiG , JefferyD , KapposL , MontalbanX , BoykoA , RoccaMA , et al. Placebo‐controlled trial of oral laquinimod for multiple sclerosis. New England Journal of Medicine2012;366(11):1000‐9. ">Comi 2012a</a>). Two articles (<a href="./references#CD010475-bbs2-0005" title="ComiG , VollmerT , SorensenPS , ArnoldD , FilippiM , StatinovO , et al. Pooled analyses from the ALLEGRO and BRAVO trials on the safety and tolerability of laquinimod as a multiple sclerosis treatment. Neurology2012; Vol. 78. ">Comi 2012b</a>; <a href="./references#CD010475-bbs2-0008" title="VollmerT , ComiG , SorensenPS , ArnoldD , FilippiM , StatinovaO , et al. Clinical efficacy of laquinimod for the treatment of multiple sclerosis; pooled analyses from the ALLEGRO and BRAVO phase III trials. Neurology2012; Vol. 78. ">Vollmer 2012</a>) were multiple reports with pooled analyses from the two studies (<a href="./references#CD010475-bbs2-0001" title="ComiG , JefferyD , KapposL , MontalbanX , BoykoA , RoccaMA , et al. Placebo‐controlled trial of oral laquinimod for multiple sclerosis. New England Journal of Medicine2012;366(11):1000‐9. ">Comi 2012a</a>; <a href="./references#CD010475-bbs2-0009" title="VollmerTL , Soelberg SorensenP , ArnoldDL , on behalf of the BRAVO study. A placebo‐controlled and active comparator phase III trial (BRAVO) for relapsing‐remitting multiple sclerosis. Multiple Sclerosis2011;17:S507‐24, Abstract 148. ">Vollmer 2011</a>). One study (<a href="./references#CD010475-bbs2-0009" title="VollmerTL , Soelberg SorensenP , ArnoldDL , on behalf of the BRAVO study. A placebo‐controlled and active comparator phase III trial (BRAVO) for relapsing‐remitting multiple sclerosis. Multiple Sclerosis2011;17:S507‐24, Abstract 148. ">Vollmer 2011</a>) was completed in December 2011, but it lacked any full article except for an abstract presentation. We failed to obtain any further information and data from the principal investigator or the pharmaceutical industries. This study was listed in the studies awaiting classification. Only one study met the inclusion criteria (<a href="./references#CD010475-bbs2-0001" title="ComiG , JefferyD , KapposL , MontalbanX , BoykoA , RoccaMA , et al. Placebo‐controlled trial of oral laquinimod for multiple sclerosis. New England Journal of Medicine2012;366(11):1000‐9. ">Comi 2012a</a>). One RCT is currently ongoing (<a href="./references#CD010475-bbs2-0010" title="The Efficacy and Safety and Tolerability of Laquinimod in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) (CONCERTO). http://www.clinicaltrials.gov/ct2/show/NCT01707992 (Accessed 10 July 2013). ">NCT01707992</a>). </p> </section> <section id="CD010475-sec-0057"> <h4 class="title">Included studies</h4> <p>The study (<a href="./references#CD010475-bbs2-0001" title="ComiG , JefferyD , KapposL , MontalbanX , BoykoA , RoccaMA , et al. Placebo‐controlled trial of oral laquinimod for multiple sclerosis. New England Journal of Medicine2012;366(11):1000‐9. ">Comi 2012a</a>) evaluated the efficacy, safety and tolerability of laquinimod at a dose of 0.6 mg orally administered once daily as capsules in adult patients with RRMS (n = 1106). </p> <section id="CD010475-sec-0058"> <h5 class="title">Characteristics of the study design</h5> <p>The study was a randomised, double‐blind, placebo‐controlled, parallel group, 24‐month, phase Ⅲ study. </p> </section> <section id="CD010475-sec-0059"> <h5 class="title">Characteristics of the participants</h5> <p>All participants had a diagnosis of definite MS according to the 2005 revised McDonald criteria (<a href="./references#CD010475-bbs2-0035" title='PolmanCH , ReingoldSC , EdanG , FilippiM , HartungHP , KapposL , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology2005;58(6):840‐6. '>Polman 2005a</a>), an age ranging from 18 to 55 years, a relapsing‐remitting clinical course, an entry EDSS score of ≤ 5.5 and an entry disease duration of ≥ 6 months. All patients were untreated previously or still had disease activity in the previous two years even though they had received disease‐modifying agents. The clinical and demographic characteristics of the study groups at baseline were well balanced. </p> </section> <section id="CD010475-sec-0060"> <h5 class="title">Characteristics of the interventions</h5> <p>Patients received oral administration of 0.6 mg/day of laquinimod or a matching placebo capsule for 24 months (laquinimod group, n = 550; placebo group, n = 556). </p> </section> <section id="CD010475-sec-0061"> <h5 class="title">Characteristics of the outcome measures</h5> <p>Most outcome measures in the current review were reported except for the time to confirmed disease progression. The annualised rate of relapse was reported as a primary outcome. The proportion of patients free of disability progression, the sum of the number of gadolinium‐enhancing T1‐weighted lesions and the PBVC were reported as secondary outcomes. The number of patients with adverse effects, serious adverse events and who withdrew or dropped out from the study because of adverse events were reported. </p> </section> </section> <section id="CD010475-sec-0062"> <h4 class="title">Excluded studies</h4> <p>Seven articles were excluded from this review; the reasons for their exclusion are listed in the '<a href="./references#CD010475-sec-0092" title="">Characteristics of excluded studies</a>' table. </p> </section> </section> <section id="CD010475-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>The study was at low risk of bias for all domains except for attrition. Further details of this assessment are available in the relevant section of the '<a href="./references#CD010475-sec-0091" title="">Characteristics of included studies</a>' table and are also presented in the 'Risk of bias' graph (<a href="#CD010475-fig-0001">Figure 1</a>) and 'Risk of bias' summary (<a href="#CD010475-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD010475-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010475-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010475-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010475-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010475-sec-0064"> <h4 class="title">Allocation</h4> <p>Sequence generation and allocation concealment were adequate. The risk of selection bias was low. The authors described that the randomisation list, stratified according to study centre, was computer‐generated by the statistical data management department of the sponsor. </p> </section> <section id="CD010475-sec-0065"> <h4 class="title">Blinding</h4> <p>The study was double‐blinded. The risks of performance bias and detection bias were low. The authors reported that the patients and investigators were unaware of the study assignments; neurologic assessments and general medical evaluations were conducted by two neurologists in order to minimize the possibility of unblinding. An examining neurologist with special training and certification assessed neurologic condition. The treating neurologist determined, on the basis of the EDSS score, whether a patient had a relapse, and decisions regarding both hospitalization and treatment with glucocorticoids were made at the discretion of the treating neurologist, who was unaware of the study‐group assignment. </p> </section> <section id="CD010475-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>The study had a relatively high dropout rate (21.9%) (20.5% and 23.2% in the laquinimod and placebo group, respectively). The number of and the reasons for dropping out were carefully recorded but to a large degree they were not balanced between the groups. The risks of attrition bias was high. </p> </section> <section id="CD010475-sec-0067"> <h4 class="title">Selective reporting</h4> <p>All listed outcomes were reported adequately in the study. The risk of reporting bias was low. </p> </section> <section id="CD010475-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>The study was sponsored and funded by Teva Pharmaceutical Industries, conflicts of interest may exist. </p> </section> </section> <section id="CD010475-sec-0069"> <h3 class="title" id="CD010475-sec-0069">Effects of interventions</h3> <p>We were unable to conduct meta‐analysis because only one study was included. Treatment effect estimates were not done, but if studies are available for meta‐analysis in future updates we will contact the trial authors for missing data. Treatment effects for each study will be estimated using Review Manager software (<a href="./references#CD010475-bbs2-0039" title="Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>). </p> <section id="CD010475-sec-0070"> <h4 class="title">Primary outcomes</h4> </section> <section id="CD010475-sec-0071"> <h4 class="title"><i>Efficacy</i> </h4> <p>The study reported that the mean annualised relapse rate during the 24‐month treatment period was significantly reduced in the laquinimod group as compared with the placebo group (mean ± SD, 0.30 ± 0.02 versus 0.39 ± 0.03; P = 0.002), and the risk of relapse was significantly reduced with laquinimod (hazard ratio 0.72; 95% CI 0.59 to 0.87; P &lt; 0.001). </p> </section> <section id="CD010475-sec-0072"> <h4 class="title"><i>Safety</i> </h4> <p>There were 3309 adverse events (AEs) in the laquinimod group and 2965 in the placebo group, with 87% and 81% of patients, respectively, reporting one or more events. </p> <p>AEs that occurred in at least 5% of all patients and those that occurred at a higher rate in the laquinimod group than in the placebo group included headache (125 (22.7%) versus 99 (17.8%), RR 1.3); back pain (90 (16.4%) versus 50 (9.0%), RR 1.8); arthralgia (47 (8.5%) versus 42 (7.6%), RR 1.1); diarrhoea (44 (8.0%) versus 34 (6.1%), RR 1.3); cough (41 (7.5%) versus 25 (4.5%), RR 1.7); urinary tract infection (40 (7.3%) versus 25 (4.5%), RR 1.6); elevated alanine aminotransferase (ALT) (38 (6.9%) versus15 (2.7%), RR 2.6); insomnia (36 (6.5%) versus 31 (5.6%), RR 1.2); nausea (34 (6.2%) versus 32 (5.8%), RR 1.1); abdominal pain (32 (5.8%) versus 16 (2.9%), RR 2.0); and sinusitis (29 (5.3%) versus 25 (4.5%), RR 1.2). More patients in the laquinimod group than in the placebo group had ALT levels &gt; 3 times the upper limit of normal (× ULN) and ≤ 5 × ULN (18 (3.6%) versus 2 (0.4%)). ALT levels &gt; 5 × ULN occurred equally often in the two groups (six patients in each group). </p> <p>A total of 122 serious adverse events (SAEs) were reported, in 11.1% of patients receiving laquinimod and in 9.5% of those receiving placebo. The SAEs occurring in at least two patients in the laquinimod group and those occurring at a higher frequency in the laquinimod group than in the placebo group included appendicitis (5 (0.9%) versus 1 (0.2%)); headache (2 (0.4%) versus 1 (0.2%)); uterine leiomyoma (2 (0.4%) versus 1 (0.2%)); cellulitis (2 (0.4%) versus 1 (0.2%)); diarrhoea (2 (0.4%) versus 0 (0)); fever (2 (0.4%) versus 0 (0)); peripheral oedema (2 (0.4%) versus 0 (0)); hypokalaemia (2 (0.4%) versus 0 (0)); vomiting (3 (0.2%) versus 0 (0)). There were 14 cases of neoplasms (8 (1.5%) in the laquinimod group and 6 (1.1%) in the placebo group): breast cancer (3 (0.5%) versus 1 (0.2%)); basal‐cell carcinoma (1 (0.2%) versus 1 (0.2%)); malignant lung neoplasm (1 (0.2%) versus 0 (0)); lymphoma (1 (0.2%) versus 0 (0)); oesophageal adenocarcinoma (1 (0.2%) versus 0 (0)); glioblastoma multiforme (1 (0.2%) versus 0 (0)); ovarian cancer (0 (0) versus 2 (0.4%)); prostate cancer (0 (0) versus 1 (0.2%)); and rectal cancer (0 (0) versus 1 (0.2%)). No deaths occurred in the laquinimod group, and three deaths occurred in the placebo group (from injury, suicide, and complications of pneumonia). </p> <p>More patients in the laquinimod group than in the placebo group discontinued due to AEs (42 (7.6%) versus 28 (5.0%), respectively). The common AEs (excluding elevated levels of ALT) were rarely associated with discontinuation of the study drug (3% and 1% of the laquinimod and placebo groups, respectively). Six patients (1.1%) receiving laquinimod and one receiving placebo (0.1%) discontinued the study drug because of the ALT elevation &gt; 3 × ULN and ≤ 5 × ULN. The ALT elevation &gt; 5 × ULN led to equal rates of discontinuation: 2 (0.4%) in the laquinimod group versus 1 (0.2%) in the placebo group for the ALT elevation &gt; 5 and ≤ 8 × ULN; and 3 (0.6%) in the laquinimod group versus 4 (0.8%) in the placebo group for the ALT elevation &gt; 8 × ULN. </p> <p><b>Secondary outcomes</b> </p> <p>The study reported the proportion of patients with confirmed disability progression at the last assessment, which was lower in the laquinimod group than in the placebo group (9.8% versus 14.0%; P = 0.04). The risk of disability progression as assessed by an increase in EDSS scores that was sustained for three months was significantly decreased for patients receiving laquinimod as compared with those receiving placebo (11.1% versus 15.7%; hazard ratio 0.64; 95% CI 0.45 to 0.91; P = 0.01). Laquinimod reduced the mean cumulative number of gadolinium‐enhancing lesions as compared with placebo (1.33 ± 0.14 versus 2.12 ± 0.22; rate ratio 0.63; P &lt; 0.001). Patients receiving laquinimod had a lower percentage of brain volume loss from baseline to 24 months as compared with patients receiving placebo (adjusted mean ‐0.87% versus ‐1.30%; mean difference 0.43 percentage points; P &lt; 0.001). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010475-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010475-sec-0073"></div> <section id="CD010475-sec-0074"> <h3 class="title" id="CD010475-sec-0074">Summary of main results</h3> <p>This systematic review included only one study, which targeted adult patients with a relapsing‐remitting clinical course and an entry score of 5.5 or lower on the EDSS. All included patients had an entry disease duration of at least six months but were ambulatory with no severe disability. This study was a large‐scale RCT involving 1106 patients over 24 months and it primarily evaluated laquinimod at a dose of 0.6 mg orally administered in capsule form once daily versus a matching placebo capsule on relapse, disability progression and safety. </p> <p>We were unable to perform a meta‐analysis. The results of this trial showed that laquinimod significantly reduced the risk of relapse (hazard ratio 0.72; 95% CI 0.59 to 0.87; P &lt; 0.001) and the risk of disability progression (11.1% versus15.7%; hazard ratio 0.64; 95% CI 0.45 to 0.91; P = 0.01) as compared with the placebo group. Short‐term laquinimod at 0.6 mg/day was safe and well tolerated by most patients with RRMS. However, the high risk of attrition bias that resulted from the high rate of dropouts (21.9%) made the results unconvincing. </p> </section> <section id="CD010475-sec-0075"> <h3 class="title" id="CD010475-sec-0075">Overall completeness and applicability of evidence</h3> <p>In this review, it was difficult to answer the question whether laquinimod was effective for MS. We are unable to give any recommendation for clinical practice and the use of laquinimod for adult patients with RRMS. Only one study with relatively poor methodological quality was included. Not all primary or secondary outcomes were measured and subgroup analysis or sensitivity analysis could not be performed as planned. MS is a chronic condition and needs a long‐term disease‐modifying therapy. Freedom from relapses and the absence of disability progression, as the measures of the success of DMTs, are needed over a long time duration. The pre‐specification of criteria for participants in this review, involving all accepted diagnostic criteria and clinical phenotypes, was sufficiently broad to encompass the likely diversity of studies. This review was restricted to completely randomised, double‐blind, controlled, parallel group clinical trials (RCTs) with a minimum period of follow‐up of one year, avoiding the inclusion of studies at a higher risk of bias and providing misleading evidence. </p> </section> <section id="CD010475-sec-0076"> <h3 class="title" id="CD010475-sec-0076">Quality of the evidence</h3> <p>The included study was an RCT with a sufficiently large sample size but with a high risk of attrition bias that resulted from the high rate of dropouts, which made the results unconvincing. </p> </section> <section id="CD010475-sec-0077"> <h3 class="title" id="CD010475-sec-0077">Potential biases in the review process</h3> <p>An extensive and comprehensive search was undertaken to limit bias in the review process, however a low number of RCTs were retrieved. The two authors independently assessed the eligibility of studies for inclusion in this review and extracted data, which minimised the potential for additional bias beyond that detailed in the risk of bias tables. The authors of this review had no conflicts of interest. </p> </section> <section id="CD010475-sec-0078"> <h3 class="title" id="CD010475-sec-0078">Agreements and disagreements with other studies or reviews</h3> <p>To the best of our knowledge, laquinimod for MS has not been systematically reviewed previously. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010475-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/urn:x-wiley:14651858:media:CD010475:CD010475-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_t/tCD010475-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010475-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010475-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/urn:x-wiley:14651858:media:CD010475:CD010475-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_t/tCD010475-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010475-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/full#CD010475-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010475.pub2/media/CDSR/CD010475/image_n/nCD010475-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010475.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010475-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010475-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010475-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010475-note-0002">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010475\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010475\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010475\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010475\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010475\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010475.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010475.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010475.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010475.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010475.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727148520"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010475.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727148524"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010475.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea4ff7c2e9365',t:'MTc0MDcyNzE0OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 